Skip to Content

Akten Side Effects

Generic Name: lidocaine ophthalmic

Note: This document contains side effect information about lidocaine ophthalmic. Some of the dosage forms listed on this page may not apply to the brand name Akten.

For the Consumer

Applies to lidocaine ophthalmic: ophthalmic gel/jelly, ophthalmic solution

Along with its needed effects, lidocaine ophthalmic (the active ingredient contained in Akten) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking lidocaine ophthalmic:

More Common

  • Blurred vision or other changes in vision
  • burning feeling at site of application
  • redness of the white part of eyes or inside of eyelids

Some side effects of lidocaine ophthalmic may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More Common

For Healthcare Professionals

Applies to lidocaine ophthalmic: ophthalmic gel


The frequency of the reported side effects is unknown, however, the manufacturer states the most commonly reported side effects were conjunctival hyperemia, corneal epithelial changes, headache, and burning upon instillation.[Ref]


Frequency not reported: Conjunctival hyperemia, corneal epithelial change, burning on instillation[Ref]

Nervous system

Frequency not reported: Headache[Ref]


1. "Product Information. Akten (lidocaine ophthalmic)." Akorn Inc, Buffalo Grove, IL.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.

More about Akten (lidocaine ophthalmic)

Consumer resources

Professional resources

Related treatment guides